Value through Innovation27 July 2016

Clinical Study Results

  • SILOMAT ® - Healthy
    Clinical Study Number 1265.1
    Study Indication Healthy
    Product SILOMAT ®
    Generic Name Pentoxyverine citrate
    Lab Code
    Clinical Phase I
    Study Title

    A Phase I, single-dose, two-way crossover study to investigate tolerability and potential ECG effects after a single oral dose of 192 mg pentoxyverine citrate (corresponding to 121.5 mg pentoxyverine base) in healthy male and female volunteers (randomised, single-blind, placebo-controlled)

    Study Document Trial synopsis 1265.1_CO english
  • SILOMAT ® - Healthy
    Clinical Study Number 64.9
    Study Indication Healthy
    Product SILOMAT ®
    Generic Name Clobutinol
    Lab Code
    Clinical Phase I
    Study Title

    A multiple rising dose study to investigate pharmacokinetics, tolerability, and ECG effects after oral doses of 80 mg to 320 mg t.i.d. clobutinol hydrochloride dragées for seven consecutive days in healthy male and female volunteers (randomised, double-blind, placebo-controlled within dose groups)

    Study Document Trial synopsis 64.9 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.